Ikarian Capital »

Cytomx Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $9.2k 8.9k 1.03
2024-09-30 $11k 8.9k 1.18
2024-06-30 $11k 8.9k 1.22

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Cytomx Therapeutics

Tang Capital Management
BVF
Vanguard Group
Prosight Management
Millennium Management
Acadian Asset Management
Point72 Asset Management
Jacobs Levy Equity Management
Schonfeld Strategic Advisors
Renaissance Technologies
Laurion Capital Management
BlackRock
Congress Park Capital
Altium Capital Management
ADAR1 Capital Management

View all funds holding Cytomx Therapeutics